Insights

Strong Industry Niche ZeClinics specializes in zebrafish-based drug discovery and disease modeling within the biotechnology research sector, offering tailored in vivo solutions that appeal to pharmaceutical and biotech companies seeking faster, cost-effective R&D tools.

Innovative Technologies The company's integration of CRISPR genome editing, AI, and lab automation presents opportunities to enhance collaborations with organizations seeking advanced, automated biological testing platforms and customized disease models.

Expanding Strategic Partnerships Recent collaborations, such as the partnership with Almirall and the development of cardiovascular therapies with academic institutes, suggest a potential for sales in targeted therapeutic research and early-stage drug screening services.

Focused Disease Areas ZeClinics' focus on cardiovascular disease models and therapies presents opportunities to target clients involved in cardiovascular research, regenerative medicine, and related therapeutic development.

Growing Market Potential Despite modest revenue levels, ZeClinics' active research initiatives and expanding partnership network indicate significant growth potential in providing specialized zebrafish models and genomics solutions to a broad range of biotech and pharmaceutical clients.

ZeClinics Tech Stack

ZeClinics uses 8 technology products and services including Google Fonts API, Floating UI, Yoast SEO, and more. Explore ZeClinics's tech stack below.

  • Google Fonts API
    Font Scripts
  • Floating UI
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Cloudflare Bot Management
    Security
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics
  • AddToAny Share Buttons
    Web Platform Extensions
  • AddToAny
    Widgets

Media & News

ZeClinics's Email Address Formats

ZeClinics uses at least 1 format(s):
ZeClinics Email FormatsExamplePercentage
First.Last@zeclinics.comJohn.Doe@zeclinics.com
61%
First.Middle@zeclinics.comJohn.Michael@zeclinics.com
27%
First.MiddleLast@zeclinics.comJohn.MichaelDoe@zeclinics.com
6%
Last@zeclinics.comDoe@zeclinics.com
6%

Frequently Asked Questions

Where is ZeClinics's headquarters located?

Minus sign iconPlus sign icon
ZeClinics's main headquarters is located at Carrer de Laureà Miró 408-410, Sant Feliu de Llobregat, Barcelona 08980, ES. The company has employees across 2 continents, including EuropeNorth America.

What is ZeClinics's official website and social media links?

Minus sign iconPlus sign icon
ZeClinics's official website is zeclinics.com and has social profiles on LinkedIn.

What is ZeClinics's SIC code NAICS code?

Minus sign iconPlus sign icon
ZeClinics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ZeClinics have currently?

Minus sign iconPlus sign icon
As of October 2025, ZeClinics has approximately 22 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: S. C.Head Of Genetics Area: F. D. S.Head Of Metabolic Disease Area & Senior Data Scientist: C. C. C.. Explore ZeClinics's employee directory with LeadIQ.

What industry does ZeClinics belong to?

Minus sign iconPlus sign icon
ZeClinics operates in the Biotechnology Research industry.

What technology does ZeClinics use?

Minus sign iconPlus sign icon
ZeClinics's tech stack includes Google Fonts APIFloating UIYoast SEOCloudflare Bot ManagementGoogle Tag ManagerGoogle AnalyticsAddToAny Share ButtonsAddToAny.

What is ZeClinics's email format?

Minus sign iconPlus sign icon
ZeClinics's email format typically follows the pattern of First.Last@zeclinics.com. Find more ZeClinics email formats with LeadIQ.

When was ZeClinics founded?

Minus sign iconPlus sign icon
ZeClinics was founded in 2013.
ZeClinics

ZeClinics

Biotechnology ResearchSpain11-50 Employees

ZeClinics is a leading zebrafish-expert CRO, dedicated to tailoring innovative solutions for understanding human disease and advancing drug and target discovery. Our mission is to accelerate research by providing deep in vivo insights, enabling reliable safety and efficacy assessments of new drugs and chemical compounds to reach the market faster. We challenge the traditional discovery process by integrating our expertise in zebrafish biology with cutting-edge lab automation and artificial intelligence.

As specialists in CRISPR genome editing, ZeClinics creates custom genome-edited zebrafish models to accurately mimic human diseases. This approach allows us to evaluate the biomedical relevance of candidate compounds and genes in vivo. Our unique zebrafish platforms bridge the gap between cell cultures and mammalian models, offering faster, cost-effective investigations that emphasize proof-of-principle experiments for rapid go/no-go decision making, thereby accelerating the early-stage development of new compounds.

ZeClinics offers essential services to pharmaceutical, biotech, nutraceutical, and agrochemical companies, as well as academic research institutions worldwide, helping to enhance and expedite their R&D efforts.

Section iconCompany Overview

Headquarters
Carrer de Laureà Miró 408-410, Sant Feliu de Llobregat, Barcelona 08980, ES
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $1M

    ZeClinics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    ZeClinics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.